Literature DB >> 12075295

Results of the modified trabeculotomy in the treatment of primary congenital glaucoma.

Ales Filous1, Blanka Brunová.   

Abstract

PURPOSE: To evaluate the effect of trabeculotomy employing probes with curvatures more closely corresponding to variable course of Schlemm's canal.
METHODS: Forty-six children with primary congenital glaucoma who underwent trabeculotomy with newly designed probes between 1990 and 1998 were evaluated retrospectively. One set of the newly designed instruments consists of 3 pairs of trabeculotomy probes, the curvatures of which correspond to corneal diameters of 10, 12, and 14 mm. The criteria for surgical success were intraocular pressure (IOP) below 21 mmHg and simultaneous absence of cup to disc (C/D) ratio progression and of disproportional enlargement of the cornea.
RESULTS: Forty-six children who underwent surgery over the course of 7 years were evaluated in a follow-up period from 7 to 83 months (38.4 +/- 22.5 months). A total of 102 trabeculotomies were performed in a total of 78 eyes, with the following complications: 8 large intraoperative hemorrhages, 3 small iris prolapses, 2 small descemetolyses, and 1 short iridodialysis. Postoperatively, glaucoma was successfully controlled in 68 eyes (87%), IOP fell in average from 30.81 +/- 6.55 mmHg to 16.32 +/- 5.13 mmHg (P <.00005). Visual acuity was better than 0.4 in 50 eyes and worse than 0.1 in 5 eyes at the end of the study.
CONCLUSION: The probing of the Schlemm's canal was feasible in all procedures and the number of complications was low. The success rate of surgery was high. Adaptation of the trabeculotomy probes to the Schlemm's canal curvature seems to make probing easier and safer.

Entities:  

Mesh:

Year:  2002        PMID: 12075295     DOI: 10.1067/mpa.2002.123431

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  9 in total

1.  Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics.

Authors:  Luciano Quaranta; Elena Biagioli; Francesca Galli; Davide Poli; Eliana Rulli; Ivano Riva; Lital Hollander; Andreas Katsanos; Antonio Longo; Maurizio G Uva; Valter Torri; Robert N Weinreb
Journal:  Adv Ther       Date:  2016-06-16       Impact factor: 3.845

2.  Long-term outcomes of a pseudo 360-degree trabeculotomy ab externo technique for congenital glaucoma at children's medical center.

Authors:  Robert M Saltzmann; Steven Reinecke; Xihui Lin; H Dwight Cavanagh; Jess T Whitson
Journal:  Clin Ophthalmol       Date:  2012-05-09

Review 3.  Primary congenital glaucoma: An updated review.

Authors:  Abdulrahman H Badawi; Ahmed A Al-Muhaylib; Adi Mohammed Al Owaifeer; Rakan S Al-Essa; Sami A Al-Shahwan
Journal:  Saudi J Ophthalmol       Date:  2019-11-07

4.  Long-term surgical outcomes of primary congenital glaucoma in China.

Authors:  Xiulan Zhang; Shaolin Du; Qian Fan; Shouxiong Peng; Minbin Yu; Jian Ge
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

5.  The efficacy of Ahmed glaucoma valve drainage devices in cases of adult refractory glaucoma in Indian eyes.

Authors:  Jitendra K S Parihar; Devendra P Vats; Rakesh Maggon; Vijay Mathur; Anirudh Singh; Sanjay K Mishra
Journal:  Indian J Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 1.848

6.  Surgical management in primary congenital glaucoma: four debates.

Authors:  Ta C Chang; Kara M Cavuoto
Journal:  J Ophthalmol       Date:  2013-05-22       Impact factor: 1.909

Review 7.  Review on the Management of Primary Congenital Glaucoma.

Authors:  Julia Yan Yu Chan; Bonnie Nk Choy; Alex Lk Ng; Jennifer Wh Shum
Journal:  J Curr Glaucoma Pract       Date:  2016-02-02

8.  Ab Interno Goniotomy Combined with Ab Externo Trabeculotomy in Advanced Primary Congenital Glaucoma Patients: 2-Year Follow-Up.

Authors:  Hazem Helmy
Journal:  Clin Ophthalmol       Date:  2021-02-15

9.  Primary congenital glaucoma surgery: outcomes and visual function.

Authors:  Elena Gusson; Francesca Chemello; Rosa Longo; Elia Franzolin; Roberta Vesentini; Giuseppe Verlato; Giorgio Marchini
Journal:  Int Ophthalmol       Date:  2021-07-23       Impact factor: 2.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.